Bauer, Karri A.
Puzniak, Laura A.
Yu, Kalvin C.
Klinker, Kenneth P.
Watts, Janet A.
Moise, Pamela A.
Finelli, Lyn
Gupta, Vikas
Funding for this research was provided by:
Merck Sharp & Dohme (Not applicable)
BD (Not applicable)
Article History
Received: 17 January 2023
Accepted: 10 July 2023
First Online: 24 July 2023
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki. The retrospective, de-identified data set was approved and informed consent requirements were waived by the New England Institutional Review Board (Wellesley, MA, USA; IRB No. 120180023).
: Not applicable.
: KAB, KPK, PAM, and LF are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and shareholders in Merck & Co., Inc., Kenilworth, NJ, USA. LAP was an employee of Merck and Co, Inc. at the time of the analysis and may own stock and/or hold stock options in Merck and Co, Inc. KCY and VG are employees of Becton, Dickinson and Company (BD), which was contracted by Merck to conduct the study, and JAW is a former employee. KCY and VG also own stock in BD.